Taqa Gains 80%, Nile Pharmaceuticals Nears 100% Return in 90 Days

Taqa shares gained 80% over 90 days, while Nile Pharmaceuticals approached a 100% gain, putting both stocks in focus on the Egyptian Exchange.

Nile Pharmaceuticals’ rise left the stock close to doubling in value over the period, outpacing Taqa’s advance.

Separately, Commercial International Bank–Egypt (CIB) topped the main market’s list of traded shares by turnover, excluding deals.

The figures highlight different measures of market performance: Taqa and Nile Pharmaceuticals stood out for their price gains, while CIB led by the value of shares traded.